Safer stroke prevention strategies are needed for patients with atrial fibrillation after intracranial hemorrhage

Edoxaban did not reduce stroke or systemic embolism but increased major bleeding in high-risk patients with atrial fibrillation who had had an intracranial hemorrhage, according to results presented in a Hot Line session at ESC Congress 2026.

≈